Search for: "Teva Pharma. USA, Inc. v. Sandoz, Inc."
Results 1 - 20
of 42
Sorted by Relevance
|
Sort by Date
25 Jan 2024, 8:25 pm
USA, Inc. v. [read post]
23 Jan 2015, 2:51 pm
USA, Inc. v. [read post]
31 Mar 2019, 7:48 pm
USA, Inc. v. [read post]
9 Oct 2009, 9:11 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
22 Jan 2015, 9:56 pm
USA, Inc. v. [read post]
17 Feb 2010, 8:00 am
Teva Parenteral Medicines Inc., Teva Pharmaceuticals USA Inc. and Teva Pharmaceutical Industries Ltd. [read post]
26 Jan 2015, 10:37 am
Sandoz, Inc., 574 U. [read post]
13 Sep 2013, 6:49 pm
USA, Inc. v. [read post]
1 Dec 2009, 9:45 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
28 Aug 2009, 8:11 am
Teva Pharmaceuticals USA, Inc. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to… [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
16 Jun 2010, 3:02 pm
Sandoz, Inc. [read post]
25 Apr 2017, 9:25 am
USA Inc. v. [read post]
14 Apr 2014, 3:51 pm
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]